GI Oncology
From the Journals
Pandemic-related CRC screening delays affect older adults most
Since previously unscreened 65-year-olds lose the most benefit from delayed colorectal cancer screenings, they should be prioritized when access...
News
Inhibiting adenosine pathways may be key to CRC treatment
New research suggests mechanisms behind how adenosine leads to immunosuppression in the tumor microenvironment.
From the Journals
After index colonoscopy, what’s the CRC risk in 40- to 49-year-olds vs. 50- to 59-year-olds?
Advanced neoplasia risk is lower in younger patients when no adenoma is detected on index colonoscopy, new research indicates.
From the Journals
Ultraprocessed foods tied to higher risk for CRC, death from heart disease
Two new studies provide more evidence to support policies that limit ultraprocessed foods and promote consumption of fresh or minimally processed...
From the Journals
Fine-needle aspiration alternative allows closer look at pancreatic cystic lesions
Through-the-needle microforceps biopsy allow next-generation sequencing to be paired with histology for accurate results.
From the Journals
Can folic acid halt or reverse progression of gastric precancerous conditions?
A meta-analysis suggests folic acid supplementation has the potential to halt or even reverse progression of gastric precancerous conditions.
From the Journals
New blood test could reshape early CRC screening
A new assay that identifies a specific combination of microRNA strands may expand colorectal cancer screening to younger ages in the face of...
From the Journals
Higher ADR continues to show ‘strong, consistent’ link with lower interval CRC
The reduction in risk over a broad range of ADRs underscores the importance of an effective colonoscopy.
From the Journals
Barrett’s esophagus: AGA screening update ‘goes above and beyond’
New American Gastroenterological Association document suggests dropping GERD as a prerequisite for screening, among other advice statements.
From the Journals
Liver cancer risk persists after direct-acting antiviral treatment for HCV
“Even with that decline in risk up to 7 years after eradication of hepatitis C with direct-acting antivirals, the risk is still high enough to...
Latest News
Medicare to cover colonoscopy after positive fecal test
The benefit expansion is a “huge win” for patients, according to the AGA, as it represents the end of out-of-pocket costs for CRC screening.